MetaCap

Globus Medical Earnings

NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD

74.65+1.32 (+1.80%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$1.20

Globus Medical earnings summary

Globus Medical is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $1.20. In its most recent report on Aug 6, 2026 (Q2 2026), GMED posted EPS of $1.10. Revenue for the quarter was $789.6 million.

Quarterly EPS is down 26.2% from the same quarter a year earlier. Across the last 16 reports, GMED shares moved an average of 2.9% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

GMED earnings history

Globus Medical reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 6, 2026—$1.10—+4.3%
May 7, 2026—$0.90—-1.7%
Feb 24, 2026—$1.01—-8.8%
Nov 6, 2025—$0.88—+0.7%
Aug 7, 2025—$1.49—+3.3%
May 8, 2025—$0.54—+9.7%
Feb 20, 2025—$0.19—+0.0%
Nov 5, 2024—$0.38—+0.3%
Aug 6, 2024—$0.23—-4.6%
May 7, 2024—$-0.05—-0.5%
Feb 21, 2024—$0.01—-3.3%
Nov 7, 2023—$0.01—+3.2%
Aug 3, 2023—$0.57—+0.6%
May 4, 2023—$0.48—-2.8%
Feb 21, 2023—$0.48—+1.0%
Nov 8, 2022—$0.47—-1.9%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related